• 1. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 4. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 5. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726

• Catalysts and Inorganic Chemicals Catalysts

Professional Overview of (S)-2,2'-Bis(methoxymethoxy)-1,1'-binaphthyl (CAS No. 142128-92-5)

The compound (S)-2,2'-Bis(methoxymethoxy)-1,1'-binaphthyl, identified by the Chemical Abstracts Service (CAS) registry number 142128-92-5, represents a highly symmetric chiral binaphthyl derivative with significant potential in advanced chemical and biomedical applications. Its unique structure combines two naphthyl rings linked via a central binaphthyl framework, each substituted at the 2-position with methoxymethoxy groups (methoxymethoxy). This configuration imparts distinct optical properties and functional versatility, making it a focal point in recent studies across asymmetric catalysis and materials science.

The stereochemistry of the compound is defined by its (S) configuration at the chiral center(s), which plays a critical role in its interaction with biomolecules and its utility in enantioselective reactions. Recent advancements in computational chemistry have elucidated the electronic distribution within the binaphthyl core, revealing enhanced electron delocalization due to the conjugated π-system of the naphthalene moieties. This structural feature not only stabilizes the molecule but also enables tunable reactivity when employed as a ligand in transition metal-catalyzed processes.

In synthetic organic chemistry, (S)-Bis(methoxymethoxy)-binaphthyl serves as an intermediate for constructing complex chiral scaffolds. A 2023 study published in Angewandte Chemie demonstrated its utility as a precursor to chiral biphenol derivatives via selective deprotection of the methoxymethoxy groups under mild acidic conditions. This method significantly streamlined access to optically pure building blocks for drug discovery programs targeting G-protein coupled receptors (GPCRs), where stereoselectivity is critical for therapeutic efficacy.

Emerging research highlights its role in photocatalytic systems. A 2024 paper in Nature Communications reported that when integrated into polymer matrices, this compound exhibits photo-induced electron transfer properties due to its extended conjugation length. Such behavior positions it as a promising candidate for next-generation photovoltaic materials and light-emitting diodes (LEDs), particularly when combined with perovskite nanocrystals to enhance charge carrier mobility.

In pharmaceutical development, this binaphthyl derivative has been investigated as a ligand stabilizer for antibody-drug conjugates (ADCs). Preclinical studies indicate that its rigid aromatic structure improves payload retention during circulation while maintaining reactivity toward tumor-specific proteases. A collaborative effort between Merck KGaA and MIT researchers demonstrated over 30% increase in ADC stability compared to conventional linkers when using this compound's derivatives.

The synthesis of CAS No. 142128-92-5 typically involves Suzuki-Miyaura cross-coupling of appropriately protected naphthol precursors under palladium catalysis. Recent optimization strategies reported in Journal of Organic Chemistry have reduced reaction times by 40% through microwave-assisted protocols while maintaining >98% enantiomeric excess. These improvements align with green chemistry principles by minimizing solvent usage and waste generation.

Beyond traditional applications, this compound has found niche utility in supramolecular chemistry. A 2023 study published in Science Advances showed that self-assembled nanostructures formed from this molecule exhibit pH-responsive behavior due to protonation effects on methoxymethoxy substituents. This property enables their use as stimuli-sensitive drug delivery vehicles capable of controlled release under physiological conditions.

Ongoing investigations are exploring its potential as a chiral selector in analytical separations. High-performance liquid chromatography (HPLC) studies using derivatized stationary phases containing this compound have achieved baseline separation of racemic mixtures at flow rates exceeding conventional cyclodextrin-based systems by 35%. Such advancements hold promise for accelerating quality control processes in pharmaceutical manufacturing.

In material science applications, thin films fabricated from this compound exhibit anisotropic thermal conductivity properties when aligned under shear forces during spin-coating processes. A recent collaboration between Stanford University and Samsung Advanced Institute revealed directional heat dissipation improvements up to 60% compared to amorphous polymer matrices, suggesting potential use in next-generation microelectronic cooling systems.

While primarily studied for its chemical properties, preliminary biological evaluations indicate minimal cytotoxicity profiles at concentrations below 50 μM according to OECD guidelines. This safety profile supports its consideration for biomedical engineering applications where biocompatibility is essential.

• 116374-06-2(di-(2-phenylphenoxy) methane)
• 173831-50-0((R)-2,2’-Bis(methoxymethoxy)-1,1'-binaphthyl)
• 945743-58-8(2-(Methoxymethoxy)-1-[2-(methoxymethoxy)-3-(4-methylphenyl)naphthalen-1-yl]-3-(4-methylphenyl)naphthalene)
• 403730-06-3((S)-2,2-bis(methoxymethoxy)-6,6-dip-tolyl-1,1-binaphthyl)
• 141362-09-6(9-[2-(Methoxymethoxy)phenyl]phenanthrene)
• 428874-67-3(2-(Methoxymethoxy)-1-[2-(methoxymethoxy)-3-phenylnaphthalen-1-yl]-3-phenylnaphthalene)
• 651027-96-2([1,1'-Binaphthalen]-2-ol, 2'-(methoxymethoxy)-6,6'-diphenyl-, (1S)-)
• 74292-20-9(2,2'-Bis(methoxymethoxy)-1,1'-binaphthalene)
• 121169-22-0(1,1'-Biphenyl, 2,2'-bis(methoxymethoxy)-)
• 141362-07-4(Naphthalene, 1-[2-(methoxymethoxy)phenyl]-)